{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:31:59Z","timestamp":1780680719437,"version":"3.54.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The morbidity and mortality in community-acquired bacterial meningitis (CABM) remain substantial, and the etiology, clinical characteristics, treatment outcomes and predictors of poor prognosis must be assessed regularly. The aim of this study was to identify the distribution of etiological agents and their relationship with clinical characteristics, treatment and outcomes in this cohort of patients with CABM.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Our retrospective chart review analyzed the causative microorganisms, clinical characteristics, laboratory findings, treatment and outcomes of 159 adults with CABM hospitalized in the Infectious Diseases Centre of Vilnius University Hospital from January 1, 2009 to December 31, 2016. A Glasgow Outcome Scale (GOS) score\u2009\u2264\u20093 was defined as unfavorable outcome. Predictors of an unfavorable outcome were identified through logistic regression analysis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The median patient age was 36 (IQR 24\u201356), and 51.6% were male. Microbiologically confirmed causative agents were identified in 80 (50.3%) patients: <jats:italic>N. meningitidis<\/jats:italic> in 55 (34.6%) patients with serotype B accounting for 85% of cases, <jats:italic>S. pneumoniae<\/jats:italic> in 15 (9.4%), <jats:italic>L. monocytogenes<\/jats:italic> in 5 (3.1%) and other in 5 (3.1%). The clinical triad of fever, neck stiffness and a change in mental status was present in 59.1% of patients. Coexisting conditions and comorbidities were similar in all groups stratified by etiology. Initial antimicrobial treatment consisted of penicillin in 78 patients (49.1%) and ceftriaxone in 72 patients (45.3%). The median time in which antibiotic treatment was started was 40\u2009min (IQR 30.0\u201390.0). The outcome was unfavorable in 15.7% of episodes and death occurred in 5.7% of cases and did not differ according to the causative agent. Risk factors for an unfavorable outcome were age\u2009&gt;\u200965\u2009years, coexisting pneumonia and a platelet count &lt;150x10e9\/l.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The most common causative agent of CABM was <jats:italic>N. meningitidis<\/jats:italic>, with serotype B clearly dominant. Causative agents did not influence the disease outcome. The strongest risk factors for an unfavorable outcome were older age, pneumonia and a low platelet count. Since the introduction of routine vaccination against meningococcus B for infants in Lithuania in 2018, the national vaccination policy may hopefully contribute to a decrease in the incidence of serogroup B meningococcal disease in the Lithuanian population.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05462-0","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T10:03:16Z","timestamp":1602064996000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Retrospective analysis of the etiology, clinical characteristics and outcomes of community-acquired bacterial meningitis in the University Infectious Diseases Centre in Lithuania"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4400-9547","authenticated-orcid":false,"given":"E.","family":"Matulyte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kiveryte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Paulauskiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Liukpetryte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vaikutyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Matulionyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"issue":"Suppl 2","key":"5462_CR1","doi-asserted-by":"publisher","first-page":"B3","DOI":"10.1016\/j.vaccine.2011.12.062","volume":"30","author":"D Pace","year":"2012","unstructured":"Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(Suppl 2):B3\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.062.","journal-title":"Vaccine"},{"issue":"6","key":"5462_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198772","volume":"13","author":"AM Oordt-Speets","year":"2018","unstructured":"Oordt-Speets AM, Bolijn R, van Hoorn RC, Bhavsar A, Kyaw MH. Global etiology of bacterial meningitis: a systematic review and meta-analysis. PLoS One. 2018;13(6):e0198772. https:\/\/doi.org\/10.1371\/journal.pone.0198772.","journal-title":"PLoS One"},{"issue":"4","key":"5462_CR3","first-page":"81","volume":"41","author":"J Fuentes-Antr\u00e1s","year":"2019","unstructured":"Fuentes-Antr\u00e1s J, Ram\u00edrez-Torres M, Osorio-Mart\u00ednez E, Lorente M, Lorenzo-Almor\u00f3s A, Lorenzo O, et al. Acute community-acquired bacterial meningitis: update on clinical presentation and prognostic factors. New Microbiol. 2019;41(4):81\u20137.","journal-title":"New Microbiol"},{"issue":"10063","key":"5462_CR4","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1016\/S0140-6736(16)30654-7","volume":"388","author":"F McGill","year":"2016","unstructured":"McGill F, Heyderman RS, Panagiotou S, Tunkel AR, Solomon T. Acute bacterial meningitis in adults. Lancet. 2016;388(10063):3036\u201347. https:\/\/doi.org\/10.1016\/S0140-6736(16)30654-7.","journal-title":"Lancet."},{"issue":"2","key":"5462_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1089\/apc.2017.0286","volume":"32","author":"KJ Vigil","year":"2018","unstructured":"Vigil KJ, Salazar L, Hasbun R. Community-acquired meningitis in HIV-infected patients in the United States. AIDS Patient Care STDs. 2018;32(2):42\u20137. https:\/\/doi.org\/10.1089\/apc.2017.0286.","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"5462_CR6","first-page":"B4119","volume":"57","author":"CT Brandt","year":"2010","unstructured":"Brandt CT. Experimental studies of pneumococcal meningitis. Dan Med Bull. 2010;57(1):B4119.","journal-title":"Dan Med Bull"},{"key":"5462_CR7","unstructured":"European Centre for disease Prevention and Control. Invasive meningococcal disease - Annual Epidemiological Report for 2017. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER_for_2017-invasive-meningococcal-disease.pdf."},{"issue":"19","key":"5462_CR8","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1001\/jama.1989.03430190084036","volume":"262","author":"A Spanos","year":"1989","unstructured":"Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA. 1989;262(19):2700\u20137.","journal-title":"JAMA"},{"key":"5462_CR9","volume-title":"Public health management of sporadic cases of invasive meningococcal disease and their contacts","author":"European Centre for Disease Prevention and Control","year":"2010","unstructured":"European Centre for Disease Prevention and Control. Public health management of sporadic cases of invasive meningococcal disease and their contacts. Stockholm: ECDC; 2010. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/1010_GUI_Meningococcal_guidance.pdf."},{"key":"5462_CR10","volume-title":"Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU\/EEA","author":"European Centre for Disease Prevention and Control","year":"2017","unstructured":"European Centre for Disease Prevention and Control. Expert opinion on the introduction of the meningococcal B (4CMenB) vaccine in the EU\/EEA. Stockholm: ECDC; 2017. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Introduction-of-4CMenB-vaccine.pdf."},{"key":"5462_CR11","volume-title":"Management of head injuries","author":"B Jennett","year":"1981","unstructured":"Jennett B, Teasdale G. Management of head injuries. 2nd ed. Philadelphia: F.A. Davis; 1981.","edition":"2"},{"issue":"3","key":"5462_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1017\/S0950268805005595","volume":"134","author":"AB Gjini","year":"2006","unstructured":"Gjini AB, Stuart JM, Lawlor DA, et al. Changing epidemiology of bacterial meningitis among adults in England and Wales 1991-2002. Epidemiol Infect. 2006;134(3):567\u20139. https:\/\/doi.org\/10.1017\/S0950268805005595.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"5462_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archinte.1997.00440250077009","volume":"157","author":"B Sigurdard\u00f3ttir","year":"1997","unstructured":"Sigurdard\u00f3ttir B, Bj\u00f6rnsson OM, J\u00f3nsd\u00f3ttir KE, Erlendsd\u00f3ttir H, Gudmundsson S. Acute bacterial meningitis in adults. A 20-year overview. Arch Intern Med. 1997;157(4):425\u201330. https:\/\/doi.org\/10.1001\/archinte.1997.00440250077009.","journal-title":"Arch Intern Med"},{"issue":"Suppl 3","key":"5462_CR14","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","volume":"22","author":"D van de Beek","year":"2016","unstructured":"van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(Suppl 3):S37\u201362. https:\/\/doi.org\/10.1016\/j.cmi.2016.01.007.","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"5462_CR15","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","volume":"364","author":"MC Thigpen","year":"2011","unstructured":"Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1005384.","journal-title":"N Engl J Med"},{"issue":"2","key":"5462_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00401-015-1531-z","volume":"131","author":"KS Doran","year":"2016","unstructured":"Doran KS, Fulde M, Gratz N, et al. Host-pathogen interactions in bacterial meningitis. Acta Neuropathol. 2016;131(2):185\u2013209. https:\/\/doi.org\/10.1007\/s00401-015-1531-z.","journal-title":"Acta Neuropathol"},{"key":"5462_CR17","unstructured":"Public Health England. Invasive meningococcal disease in England: annual laboratory confirmed reports for epidemiological year 2017 to 2018. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/751821\/hpr3818_IMD.pdf."},{"issue":"24","key":"5462_CR18","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1016\/j.vaccine.2012.03.011","volume":"30","author":"SN Ladhani","year":"2012","unstructured":"Ladhani SN, Flood JS, Ramsay ME, et al. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine. 2012;30(24):3710\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2012.03.011.","journal-title":"Vaccine"},{"key":"5462_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fped.2018.00321","volume":"6","author":"S Nadel","year":"2018","unstructured":"Nadel S, Ninis N. Invasive meningococcal disease in the vaccine era. Front Pediatr. 2018;6:321. https:\/\/doi.org\/10.3389\/fped.2018.00321.","journal-title":"Front Pediatr"},{"issue":"3","key":"5462_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/cid\/cit243","volume":"57","author":"S Mandal","year":"2013","unstructured":"Mandal S, Wu HM, MacNeil JR, et al. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States. Clin Infect Dis. 2013;57(3):344\u20138. https:\/\/doi.org\/10.1093\/cid\/cit243.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5462_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11481-016-9705-6","volume":"12","author":"KEB van Veen","year":"2017","unstructured":"van Veen KEB, Brouwer MC, van der Ende A, van de Beek D. Bacterial meningitis in patients using immunosuppressive medication: a population-based prospective Nationwide study. J NeuroImmune Pharmacol. 2017;12(2):213\u20138. https:\/\/doi.org\/10.1007\/s11481-016-9705-6.","journal-title":"J NeuroImmune Pharmacol"},{"issue":"1","key":"5462_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s12879-019-4146-5","volume":"19","author":"SN Ladhani","year":"2019","unstructured":"Ladhani SN, Campbell H, Lucidarme J, et al. Invasive meningococcal disease in patients with complement deficiencies: a case series (2008-2017). BMC Infect Dis. 2019;19(1):522. https:\/\/doi.org\/10.1186\/s12879-019-4146-5.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5462_CR23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4161\/viru.26515","volume":"5","author":"LA Lewis","year":"2014","unstructured":"Lewis LA, Ram S. Meningococcal disease and the complement system. Virulence. 2014;5(1):98\u2013126. https:\/\/doi.org\/10.4161\/viru.26515.","journal-title":"Virulence"},{"issue":"5","key":"5462_CR24","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S1473-3099(16)30521-7","volume":"17","author":"C Charlier","year":"2017","unstructured":"Charlier C, Perrodeau \u00c9, Leclercq A, et al. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. Lancet Infect Dis. 2017;17(5):510\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(16)30521-7.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"5462_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jinf.2011.02.010","volume":"62","author":"K Sakushima","year":"2011","unstructured":"Sakushima K, Hayashino Y, Kawaguchi T, Jackson JL, Fukuhara S. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Inf Secur. 2011;62(4):255\u201362. https:\/\/doi.org\/10.1016\/j.jinf.2011.02.010.","journal-title":"J Inf Secur"},{"issue":"2","key":"5462_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1469-0691.2005.01327.x","volume":"12","author":"E Bronska","year":"2006","unstructured":"Bronska E, Kalmusova J, Dzupova O, Maresova V, Kriz P, Benes J. Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. Clin Microbiol Infect. 2006;12(2):137\u201341. https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01327.x.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5462_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1128\/CMR.00070-09","volume":"23","author":"MC Brouwer","year":"2010","unstructured":"Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23(3):467\u201392. https:\/\/doi.org\/10.1128\/CMR.00070-09.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"5462_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1136\/jramc-2016-000695","volume":"163","author":"BC Millar","year":"2017","unstructured":"Millar BC, Moore PJA, Moore JE. Meningococcal disease: has the battle been won? J R Army Med Corps. 2017;163(4):235\u201341. https:\/\/doi.org\/10.1136\/jramc-2016-000695.","journal-title":"J R Army Med Corps"},{"issue":"1","key":"5462_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/bmb\/ldz023","volume":"131","author":"J Ellis","year":"2019","unstructured":"Ellis J, Luintel A, Chandna A, Heyderman RS. Community-acquired acute bacterial meningitis in adults: a clinical update. Br Med Bull. 2019;131(1):57\u201370. https:\/\/doi.org\/10.1093\/bmb\/ldz023.","journal-title":"Br Med Bull"},{"issue":"5, Neuroinfecti","key":"5462_CR30","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1212\/CON.0000000000000660","volume":"24","author":"LE Davis","year":"2018","unstructured":"Davis LE. Acute Bacterial Meningitis. Continuum (Minneap Minn). 2018;24(5, Neuroinfectious Disease):1264\u201383. https:\/\/doi.org\/10.1212\/CON.0000000000000660.","journal-title":"Continuum (Minneap Minn)"},{"issue":"4","key":"5462_CR31","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ncl.2018.06.007","volume":"36","author":"AHA Figueiredo","year":"2018","unstructured":"Figueiredo AHA, Brouwer MC, van de Beek D. Acute community-acquired bacterial meningitis. Neurol Clin. 2018;36(4):809\u201320. https:\/\/doi.org\/10.1016\/j.ncl.2018.06.007.","journal-title":"Neurol Clin"},{"issue":"15","key":"5462_CR32","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1212\/WNL.0b013e31826e2684","volume":"79","author":"SG Heckenberg","year":"2012","unstructured":"Heckenberg SG, Brouwer MC, van der Ende A, van de Beek D. Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology. 2012;79(15):1563\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e31826e2684.","journal-title":"Neurology"},{"issue":"2","key":"5462_CR33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/cid\/cit250","volume":"57","author":"MM Koopmans","year":"2013","unstructured":"Koopmans MM, Brouwer MC, Bijlsma MW, et al. Listeria monocytogenes sequence type 6 and increased rate of unfavorable outcome in meningitis: epidemiologic cohort study. Clin Infect Dis. 2013;57(2):247\u201353. https:\/\/doi.org\/10.1093\/cid\/cit250.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5462_CR34","first-page":"105","volume":"24","author":"P Pagliano","year":"2016","unstructured":"Pagliano P, Ascione T, Boccia G, De Caro F, Esposito S. Listeria monocytogenes meningitis in the elderly: epidemiological, clinical and therapeutic findings. Infez Med. 2016;24(2):105\u201311.","journal-title":"Infez Med"},{"key":"5462_CR35","unstructured":"Laboratory surveillance of invasive infectious agents (in Lithuanian). Available from: http:\/\/www.nvspl.lt\/index.php?548023473."},{"issue":"2","key":"5462_CR36","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cmi.2017.06.021","volume":"24","author":"J Bodilsen","year":"2018","unstructured":"Bodilsen J, Brandt CT, Sharew A, et al. Early versus late diagnosis in community-acquired bacterial meningitis: a retrospective cohort study. Clin Microbiol Infect. 2018;24(2):166\u201370. https:\/\/doi.org\/10.1016\/j.cmi.2017.06.021.","journal-title":"Clin Microbiol Infect"},{"key":"5462_CR37","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12879-016-1711-z","volume":"16","author":"J Bodilsen","year":"2016","unstructured":"Bodilsen J, Dalager-Pedersen M, Sch\u00f8nheyder HC, Nielsen H. Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study. BMC Infect Dis. 2016;16:392. https:\/\/doi.org\/10.1186\/s12879-016-1711-z.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"5462_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004405.pub5","volume":"2015","author":"MC Brouwer","year":"2015","unstructured":"Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2015;2015(9):CD004405. https:\/\/doi.org\/10.1002\/14651858.CD004405.pub5.","journal-title":"Cochrane Database Syst Rev"},{"key":"5462_CR39","volume-title":"Bacterial meningitis","author":"World Health Organization (WHO)","year":"2019","unstructured":"World Health Organization (WHO). Bacterial meningitis. 2019. Available from: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/surveillance_type\/sentinel\/meningitis_surveillance\/en\/."},{"issue":"11","key":"5462_CR40","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.3390\/ijms19113555","volume":"19","author":"B Yau","year":"2018","unstructured":"Yau B, Hunt NH, Mitchell AJ, Too LK. Blood\u2013brain barrier pathology and CNS outcomes in Streptococcus pneumoniae meningitis. Int J Mol Sci. 2018;19(11):3555. https:\/\/doi.org\/10.3390\/ijms19113555.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5462_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jinf.2016.04.009","volume":"73","author":"MJ Lucas","year":"2016","unstructured":"Lucas MJ, Brouwer MC, van de Beek D. Neurological sequelae of bacterial meningitis. J Inf Secur. 2016;73(1):18\u201327. https:\/\/doi.org\/10.1016\/j.jinf.2016.04.009.","journal-title":"J Inf Secur"},{"issue":"4","key":"5462_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/MD.0b013e318180a6b4","volume":"87","author":"SG Heckenberg","year":"2008","unstructured":"Heckenberg SG, de Gans J, Brouwer MC, et al. Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore). 2008;87(4):185\u201392. https:\/\/doi.org\/10.1097\/MD.0b013e318180a6b4.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"5462_CR43","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMra052116","volume":"354","author":"D van de Beek","year":"2006","unstructured":"van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354(1):44\u201353. https:\/\/doi.org\/10.1056\/NEJMra052116.","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05462-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05462-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05462-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T01:50:41Z","timestamp":1633571441000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05462-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5462"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05462-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Lithuanian Bioethics Committee. The ethics approval number is 158200\u201318\u2013982-485. Informed consent and its written form were obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"733"}}